Search research articles
Contact Us
Filters
Showing results (521-530 of 572) with videos related to
Page
of 58
Sort By:
Elife
|
May 2, 2025
Correction: <i>TP53</i> drives invasion through expression of its Δ133p53β variant
Gilles Gadea, Nikola Arsic, Kenneth Fernandes, et al.
Blood
|
July 24, 2024
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited
Jan-Inge Henter, Elena Sieni, Julia Eriksson, et al.
Blood
|
April 18, 2019
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
Paul La Rosée, AnnaCarin Horne, Melissa Hines, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen
Rebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
Elife
|
September 16, 2016
<i>TP53</i> drives invasion through expression of its Δ133p53β variant
Gilles Gadea, Nikola Arsic, Kenneth Fernandes, et al.
Scientific Reports
|
March 29, 2017
Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
Matthew P Humphries, Sreekumar Sundara Rajan, Hedieh Honarpisheh, et al.
Journal of Clinical Immunology
|
September 29, 2021
Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD
Danielle E Arnold, Rofida Nofal, Connor Wakefield, et al.
Blood Advances
|
April 18, 2025
The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in lymphoma patients
Adi Zoref-Lorenz, Jun Murakami, Ronit Gurion, et al.
JAMA
|
May 13, 2010
Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia
Elliott P Vichinsky, Lynne D Neumayr, Jeffrey I Gold, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases
Jonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
Page
of 58
Search research articles
Search
Showing results (521-530 of 572) with videos related to
Sort By:
Page
of 58
Elife
|
May 2, 2025
Correction: <i>TP53</i> drives invasion through expression of its Δ133p53β variant
Gilles Gadea, Nikola Arsic, Kenneth Fernandes, et al.
Blood
|
July 24, 2024
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited
Jan-Inge Henter, Elena Sieni, Julia Eriksson, et al.
Blood
|
April 18, 2019
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
Paul La Rosée, AnnaCarin Horne, Melissa Hines, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen
Rebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
Elife
|
September 16, 2016
<i>TP53</i> drives invasion through expression of its Δ133p53β variant
Gilles Gadea, Nikola Arsic, Kenneth Fernandes, et al.
Scientific Reports
|
March 29, 2017
Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
Matthew P Humphries, Sreekumar Sundara Rajan, Hedieh Honarpisheh, et al.
Journal of Clinical Immunology
|
September 29, 2021
Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD
Danielle E Arnold, Rofida Nofal, Connor Wakefield, et al.
Blood Advances
|
April 18, 2025
The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in lymphoma patients
Adi Zoref-Lorenz, Jun Murakami, Ronit Gurion, et al.
JAMA
|
May 13, 2010
Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia
Elliott P Vichinsky, Lynne D Neumayr, Jeffrey I Gold, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases
Jonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
Page
of 58